Merck KGaA (ETR:MRK – Get Free Report) dropped 1.3% during trading on Tuesday . The company traded as low as €155.15 ($172.39) and last traded at €155.55 ($172.83). Approximately 414,140 shares were traded during trading, The stock had previously closed at €157.55 ($175.06).
Merck KGaA Price Performance
The company has a fifty day moving average price of €165.64 and a two-hundred day moving average price of €161.23. The company has a current ratio of 1.31, a quick ratio of 0.72 and a debt-to-equity ratio of 37.56. The firm has a market cap of $20.10 billion, a P/E ratio of 25.75, a PEG ratio of 2.57 and a beta of 0.71.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- 3 Stocks to Consider Buying in October
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- P/E Ratio Calculation: How to Assess Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Do ETFs Pay Dividends? What You Need to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
